Published in Oncol Lett on December 07, 2016
International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer (2005) 3.81
Management of non-small-cell lung cancer: recent developments. Lancet (2013) 3.51
Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer (2006) 1.82
MotifMap: a human genome-wide map of candidate regulatory motif sites. Bioinformatics (2008) 1.73
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther (2009) 1.57
Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J (1988) 1.53
The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta (1987) 1.45
ALK inhibitors in the treatment of advanced NSCLC. Cancer Treat Rev (2013) 1.43
Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer (2008) 1.33
Haptoglobin: function and polymorphism. Clin Lab (2000) 1.31
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer (2004) 1.23
Targeted therapy for non-small-cell lung cancer: past, present and future. Expert Rev Anticancer Ther (2013) 1.22
Personalized peptide vaccine for treatment of advanced cancer. Curr Med Chem (2014) 1.17
Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer (2007) 1.11
Next-generation peptide vaccines for advanced cancer. Cancer Sci (2012) 1.09
Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer (1987) 1.08
A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients. Oncol Rep (2010) 1.07
Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer. Int J Cancer (2011) 1.07
Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia (2007) 1.04
Personalized peptide vaccination in patients with refractory non-small cell lung cancer. Int J Oncol (2012) 1.03
PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer. Cancer Sci (2014) 0.90
Acute phase reaction, heterogeneity, and microheterogeneity of serum proteins as nonspecific tumor markers in lung cancer. Cancer (1987) 0.89
The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Tumour Biol (2013) 0.87
Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer. Prostate (2004) 0.87
Polymorphisms in the 5'-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens (1999) 0.85
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer. Cancer Sci (2012) 0.83
Genetic factors associated with serum haptoglobin level in a Japanese population. Clin Chim Acta (2014) 0.83
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. Cancer Sci (2007) 0.83
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens. Int J Oncol (2014) 0.83
Haptoglobin gene promoter polymorphism and haplotypes are unique in different populations. Hum Biol (2006) 0.79
Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis. PLoS One (2013) 0.79
Polymorphism of the 5'-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. J Infect Dis (1999) 0.78
Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma. Hum Pathol (2017) 0.75